Medical technology company Healthcare Holding Schweiz AG announced on Monday that it has completed the acquisition of Effectum CH-Rep AG, effectively carving out all Swiss Authorized Representative (CH-REP) services from Effectum Medical AG.
Under the Medical Devices Ordinance (MedDO SR 812.213), medical device manufacturers without a Swiss presence must appoint a CH-REP to distribute products within Switzerland.
This acquisition enhances Healthcare Holding Schweiz AG's ability to serve as a comprehensive partner for global medical technology manufacturers. The company's expanded portfolio now includes services ranging from import and distribution to full regulatory compliance. This positions Healthcare Holding Schweiz AG to offer integrated solutions to meet evolving industry needs.
Insulet expands European footprint with Omnipod 5 and Omnipod Discover launch in Spain
Frontier IP portfolio company InSignals wins EU grant and launches Parkinson's app
PharmaResearch to acquire CG USA to support North American expansion of REJURAN Cosmetics
United Therapeutics wins FDA approval for LungFX ex vivo lung perfusion device
Natera Signatera gains PMDA approval in Japan for colorectal cancer testing
Getinge launches Fluobeam LS for fluorescence‑guided small‑incision surgery
Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study
Galmed Pharmaceuticals to acquire Colospan for GI-focused platform development
Medtronic seeks expanded US approvals for Hugo robotic surgery system
Waters secures FDA clearance for BD BACTEC FXI Blood Culture System
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
ILC Dover adds Water for Injection (WFI) and custom chemical solutions to offerings
Merz Therapeutics and Kvvit sign exclusive agreement for INBRIJA in Greater China